Identifica't
Grups
Investigadors/es
Finançament
Resultats
Finançament
Finançador
:
GLENMARK PHARMACEUTICALS LIMITED
Àmbit
Internacional (no UE) (1)
Caràcter
Privat (1)
1 finançaments
- 607€
dades disponibles des de lany {0}
2021
Experience In The Field of On Potential Indications of Molecules That Inhibit Nlrp3 And Potential Techniques To Use In The Design of Drugs That Inhibit Nlrp3.
euro
607,50
Contacta
Avís legal
translate
ca
arrow_drop_down
translate
ca
arrow_drop_down
es
eu
gl
en
fr
de